nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0794	0.0879	CbGbCtD
Allylestrenol—CYP3A4—Trimethadione—epilepsy syndrome	0.0738	0.0817	CbGbCtD
Allylestrenol—CYP3A4—Felbamate—epilepsy syndrome	0.0738	0.0817	CbGbCtD
Allylestrenol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0694	0.0768	CbGbCtD
Allylestrenol—CYP3A4—Clonazepam—epilepsy syndrome	0.0628	0.0694	CbGbCtD
Allylestrenol—CYP3A4—Clobazam—epilepsy syndrome	0.0602	0.0666	CbGbCtD
Allylestrenol—CYP3A4—Rufinamide—epilepsy syndrome	0.0512	0.0566	CbGbCtD
Allylestrenol—CYP3A4—Carbamazepine—epilepsy syndrome	0.0499	0.0552	CbGbCtD
Allylestrenol—CYP3A4—Primidone—epilepsy syndrome	0.0465	0.0515	CbGbCtD
Allylestrenol—CYP3A4—Phenytoin—epilepsy syndrome	0.0447	0.0495	CbGbCtD
Allylestrenol—CYP3A4—Propofol—epilepsy syndrome	0.0417	0.0462	CbGbCtD
Allylestrenol—CYP3A4—Acetazolamide—epilepsy syndrome	0.0399	0.0441	CbGbCtD
Allylestrenol—CYP3A4—Phenobarbital—epilepsy syndrome	0.0399	0.0441	CbGbCtD
Allylestrenol—CYP3A4—Midazolam—epilepsy syndrome	0.0393	0.0435	CbGbCtD
Allylestrenol—CYP3A4—Diazepam—epilepsy syndrome	0.0378	0.0418	CbGbCtD
Allylestrenol—CYP3A4—Zonisamide—epilepsy syndrome	0.0369	0.0408	CbGbCtD
Allylestrenol—CYP3A4—Valproic Acid—epilepsy syndrome	0.0298	0.033	CbGbCtD
Allylestrenol—CYP3A4—Topiramate—epilepsy syndrome	0.0269	0.0297	CbGbCtD
Allylestrenol—Norgestimate—ABCC2—epilepsy syndrome	0.00144	0.347	CrCbGaD
Allylestrenol—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.00142	0.341	CrCbGaD
Allylestrenol—Norethindrone—CYP2C19—epilepsy syndrome	0.000497	0.12	CrCbGaD
Allylestrenol—Norethindrone—ALB—epilepsy syndrome	0.000275	0.0663	CrCbGaD
Allylestrenol—Norethindrone—ABCB1—epilepsy syndrome	0.000263	0.0633	CrCbGaD
Allylestrenol—Methyltestosterone—ALB—epilepsy syndrome	0.000262	0.063	CrCbGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	8.42e-05	0.000912	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	8.37e-05	0.000908	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	8.36e-05	0.000906	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	8.35e-05	0.000906	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	8.3e-05	0.0009	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SNRPE—epilepsy syndrome	8.19e-05	0.000888	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SSTR5—epilepsy syndrome	8.14e-05	0.000883	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SSTR4—epilepsy syndrome	8.14e-05	0.000883	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GFAP—epilepsy syndrome	8.06e-05	0.000874	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GAL—epilepsy syndrome	8.06e-05	0.000874	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GRM5—epilepsy syndrome	7.97e-05	0.000864	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP2—epilepsy syndrome	7.97e-05	0.000864	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CHRM3—epilepsy syndrome	7.97e-05	0.000864	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	7.96e-05	0.000863	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—JUNB—epilepsy syndrome	7.84e-05	0.00085	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR10—epilepsy syndrome	7.81e-05	0.000846	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	7.77e-05	0.000843	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CX3CR1—epilepsy syndrome	7.64e-05	0.000828	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	7.6e-05	0.000824	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—VDR—epilepsy syndrome	7.59e-05	0.000822	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.55e-05	0.000819	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	7.49e-05	0.000812	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CHRM2—epilepsy syndrome	7.49e-05	0.000812	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—BDKRB1—epilepsy syndrome	7.49e-05	0.000812	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CX3CL1—epilepsy syndrome	7.49e-05	0.000812	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GABBR1—epilepsy syndrome	7.29e-05	0.00079	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	7.01e-05	0.00076	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HRH3—epilepsy syndrome	6.99e-05	0.000757	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—OPRM1—epilepsy syndrome	6.88e-05	0.000746	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—NR3C1—epilepsy syndrome	6.83e-05	0.00074	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM2—epilepsy syndrome	6.82e-05	0.00074	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.77e-05	0.000734	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.6e-05	0.000715	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR3—epilepsy syndrome	6.5e-05	0.000704	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NPY—epilepsy syndrome	6.33e-05	0.000686	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ATP2A2—epilepsy syndrome	6.33e-05	0.000686	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SIRT1—epilepsy syndrome	6.31e-05	0.000684	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—VDR—epilepsy syndrome	6.22e-05	0.000675	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SSTR3—epilepsy syndrome	6.17e-05	0.000669	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HSPB1—epilepsy syndrome	6.11e-05	0.000662	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CRH—epilepsy syndrome	6.11e-05	0.000662	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—OXT—epilepsy syndrome	6.11e-05	0.000662	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL2—epilepsy syndrome	6.11e-05	0.000662	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL3—epilepsy syndrome	6.11e-05	0.000662	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	6.04e-05	0.000655	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	5.92e-05	0.000641	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NPY2R—epilepsy syndrome	5.92e-05	0.000641	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR8—epilepsy syndrome	5.92e-05	0.000641	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR9—epilepsy syndrome	5.92e-05	0.000641	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SSTR1—epilepsy syndrome	5.92e-05	0.000641	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—H2AFX—epilepsy syndrome	5.9e-05	0.000639	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM3—epilepsy syndrome	5.8e-05	0.000629	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM4—epilepsy syndrome	5.8e-05	0.000629	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CA13—epilepsy syndrome	5.79e-05	0.000628	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—EIF2S1—epilepsy syndrome	5.71e-05	0.000619	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—DUSP4—epilepsy syndrome	5.7e-05	0.000617	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SSTR2—epilepsy syndrome	5.7e-05	0.000617	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—YWHAZ—epilepsy syndrome	5.69e-05	0.000617	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TSC1—epilepsy syndrome	5.68e-05	0.000616	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTK2B—epilepsy syndrome	5.68e-05	0.000616	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.65e-05	0.000613	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—NR3C1—epilepsy syndrome	5.6e-05	0.000607	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SST—epilepsy syndrome	5.52e-05	0.000599	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NTRK2—epilepsy syndrome	5.52e-05	0.000599	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR2—epilepsy syndrome	5.52e-05	0.000599	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—HSPB1—epilepsy syndrome	5.51e-05	0.000598	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM8—epilepsy syndrome	5.5e-05	0.000596	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PGF—epilepsy syndrome	5.5e-05	0.000596	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—DUSP6—epilepsy syndrome	5.48e-05	0.000594	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRA2A—epilepsy syndrome	5.41e-05	0.000586	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLAT—epilepsy syndrome	5.38e-05	0.000584	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—OPRD1—epilepsy syndrome	5.25e-05	0.000569	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GNAO1—epilepsy syndrome	5.25e-05	0.000569	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL12—epilepsy syndrome	5.19e-05	0.000563	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—BDKRB2—epilepsy syndrome	5.19e-05	0.000563	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—JUNB—epilepsy syndrome	5.1e-05	0.000553	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CNR1—epilepsy syndrome	5.1e-05	0.000553	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	5.08e-05	0.000551	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLCB1—epilepsy syndrome	5.08e-05	0.000551	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—AKT1—epilepsy syndrome	5.05e-05	0.000548	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PDYN—epilepsy syndrome	5.03e-05	0.000545	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR7—epilepsy syndrome	5.03e-05	0.000545	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM1—epilepsy syndrome	5.03e-05	0.000545	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CHRM1—epilepsy syndrome	5.03e-05	0.000545	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HTR7—epilepsy syndrome	4.97e-05	0.000539	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HBEGF—epilepsy syndrome	4.83e-05	0.000523	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT3—epilepsy syndrome	4.74e-05	0.000514	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GFAP—epilepsy syndrome	4.73e-05	0.000513	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GAL—epilepsy syndrome	4.73e-05	0.000513	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRM5—epilepsy syndrome	4.68e-05	0.000507	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP2—epilepsy syndrome	4.68e-05	0.000507	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CHRM3—epilepsy syndrome	4.68e-05	0.000507	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADAM10—epilepsy syndrome	4.63e-05	0.000502	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—JUNB—epilepsy syndrome	4.6e-05	0.000499	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CX3CR1—epilepsy syndrome	4.48e-05	0.000486	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—BDKRB1—epilepsy syndrome	4.4e-05	0.000477	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CX3CL1—epilepsy syndrome	4.4e-05	0.000477	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CHRM2—epilepsy syndrome	4.4e-05	0.000477	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.39e-05	0.000476	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—S100B—epilepsy syndrome	4.38e-05	0.000474	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SOCS3—epilepsy syndrome	4.33e-05	0.00047	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDC42—epilepsy syndrome	4.32e-05	0.000469	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GABBR1—epilepsy syndrome	4.28e-05	0.000464	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.21e-05	0.000456	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AVP—epilepsy syndrome	4.19e-05	0.000454	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HRH3—epilepsy syndrome	4.1e-05	0.000445	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—OPRM1—epilepsy syndrome	4.04e-05	0.000438	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.02e-05	0.000435	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.02e-05	0.000435	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.02e-05	0.000435	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.02e-05	0.000435	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HES1—epilepsy syndrome	3.96e-05	0.000429	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FYN—epilepsy syndrome	3.85e-05	0.000417	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	3.84e-05	0.000416	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	3.83e-05	0.000415	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR3—epilepsy syndrome	3.81e-05	0.000413	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.73e-05	0.000405	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.73e-05	0.000405	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.72e-05	0.000403	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NPY—epilepsy syndrome	3.72e-05	0.000403	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	3.72e-05	0.000403	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SIRT1—epilepsy syndrome	3.71e-05	0.000402	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	3.7e-05	0.000401	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NGF—epilepsy syndrome	3.66e-05	0.000397	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—VDR—epilepsy syndrome	3.65e-05	0.000396	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—OXT—epilepsy syndrome	3.58e-05	0.000389	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	3.58e-05	0.000389	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CRH—epilepsy syndrome	3.58e-05	0.000389	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	3.58e-05	0.000389	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	3.58e-05	0.000389	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR5—epilepsy syndrome	3.56e-05	0.000386	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.51e-05	0.000381	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	3.48e-05	0.000378	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—H2AFX—epilepsy syndrome	3.46e-05	0.000375	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	3.34e-05	0.000362	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.33e-05	0.000361	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TSC2—epilepsy syndrome	3.31e-05	0.000359	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AGT—epilepsy syndrome	3.3e-05	0.000358	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NR3C1—epilepsy syndrome	3.29e-05	0.000356	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	3.24e-05	0.000351	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SST—epilepsy syndrome	3.24e-05	0.000351	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	3.24e-05	0.000351	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOE—epilepsy syndrome	3.24e-05	0.000351	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	3.21e-05	0.000348	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.17e-05	0.000344	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—KDR—epilepsy syndrome	3.17e-05	0.000344	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	3.16e-05	0.000342	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	3.05e-05	0.000331	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.05e-05	0.00033	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	3.05e-05	0.00033	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.04e-05	0.00033	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.04e-05	0.00033	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.04e-05	0.00033	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	3.04e-05	0.00033	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	2.99e-05	0.000324	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	2.99e-05	0.000324	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	2.98e-05	0.000323	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.93e-05	0.000318	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	2.92e-05	0.000316	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	2.83e-05	0.000307	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.83e-05	0.000307	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.83e-05	0.000307	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—POMC—epilepsy syndrome	2.78e-05	0.000302	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	2.78e-05	0.000302	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL2—epilepsy syndrome	2.72e-05	0.000295	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	2.72e-05	0.000294	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.66e-05	0.000288	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.59e-05	0.000281	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—S100B—epilepsy syndrome	2.57e-05	0.000278	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	2.54e-05	0.000276	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	2.54e-05	0.000275	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.52e-05	0.000273	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.52e-05	0.000273	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGF2—epilepsy syndrome	2.46e-05	0.000267	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AVP—epilepsy syndrome	2.46e-05	0.000266	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.41e-05	0.000261	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.41e-05	0.000261	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.35e-05	0.000255	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HES1—epilepsy syndrome	2.32e-05	0.000252	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.31e-05	0.00025	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RELA—epilepsy syndrome	2.28e-05	0.000248	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.26e-05	0.000245	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FYN—epilepsy syndrome	2.26e-05	0.000245	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	2.25e-05	0.000244	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	2.25e-05	0.000244	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MTOR—epilepsy syndrome	2.24e-05	0.000243	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.22e-05	0.000241	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.17e-05	0.000235	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NGF—epilepsy syndrome	2.15e-05	0.000233	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	2.09e-05	0.000226	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.08e-05	0.000225	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP3—epilepsy syndrome	2.06e-05	0.000223	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	2.04e-05	0.000222	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.02e-05	0.000219	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—JUN—epilepsy syndrome	2e-05	0.000217	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—epilepsy syndrome	1.95e-05	0.000211	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	1.94e-05	0.000211	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AGT—epilepsy syndrome	1.94e-05	0.00021	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOE—epilepsy syndrome	1.9e-05	0.000206	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—KDR—epilepsy syndrome	1.86e-05	0.000202	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.82e-05	0.000198	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.82e-05	0.000198	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SRC—epilepsy syndrome	1.79e-05	0.000195	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.79e-05	0.000194	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.79e-05	0.000194	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	1.75e-05	0.000189	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—AKT1—epilepsy syndrome	1.72e-05	0.000186	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—POMC—epilepsy syndrome	1.63e-05	0.000177	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	1.6e-05	0.000173	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.49e-05	0.000161	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.45e-05	0.000157	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-05	0.000157	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.44e-05	0.000156	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RELA—epilepsy syndrome	1.34e-05	0.000145	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-05	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.3e-05	0.000141	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.24e-05	0.000134	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.000134	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000127	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—JUN—epilepsy syndrome	1.17e-05	0.000127	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000126	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TH—epilepsy syndrome	1.16e-05	0.000126	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-05	0.000124	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT1—epilepsy syndrome	1.12e-05	0.000121	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SRC—epilepsy syndrome	1.05e-05	0.000114	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-05	0.000111	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AKT1—epilepsy syndrome	1.01e-05	0.000109	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.66e-06	0.000105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.54e-06	0.000103	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.28e-06	0.000101	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.62e-06	9.35e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.56e-06	8.2e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.41e-06	8.03e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	6.54e-06	7.1e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.36e-06	6.9e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.8e-06	6.29e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.08e-06	5.5e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.55e-06	2.77e-05	CbGpPWpGaD
